ENZC

Healthcare Biotechnology

Enzolytics, Inc.

$0.00

+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap

1.93M

Avg Volume

3.47M

EPS

-$0.43

52W High

$0.00

52W Low

$0.00

Div. Yield

0.0%

Valuation

P/B Ratio

-0.00

P/S Ratio

41.48

EV/EBITDA

-0.26

EV/Revenue

4.89

Margins

Gross Margin 100.0%

Operating Margin (1924.3%)

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Assets

(704.7%)

Liquidity & Leverage

Current Ratio

0.01

Quick Ratio

0.01

Total Cash

5,760

Total Debt

233,122

About

Enzolytics, Inc. a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics. In addition, the company's proprietary cell line produces human monoclonal antibodies that target and neutralizes the HIV virus. Enzolytics, Inc. is based in Plano, Texas.

enzolytics.com